2.3 mln shares are nothing..Buy when you can
Cover and go long..make tons more money!
Any short is screwed and will just whine on this board.
Early trials show promise. One trial had an average survival of around three years, and in some tests, a few individuals have survived more than 10 years — eight times the average of 15 months.
Applying this technique to an earlier-stage glioma like mine might prevent it from mutating into a glioblastoma. And because it would be my immune system doing the work, there are likely to be relatively few side effects. For now I’m crossing my fingers: Randomized trials are now recruiting, with early results expected later this year.
SGNL has a very low float compared to BIOC too. They will run SGNL hard.
Omit brackets and place in browser.
monitoring system. This stock is a 5-10 bagger.
$25 easily reached.